mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.04 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.098 |
0.04 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Pazopanib |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
0.34 |
0.05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.05 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |